Landy Rebecca, Katki Hormuzd A, Huang Wen-Yi, Wang Difei, Thomas Minta, Qu Flora, Freedman Neal D, Loftfield Erikka, Shi Jianxin, Peters Ulrike, Hsu Li, Schoen Robert E, Berndt Sonja I
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Clin Transl Gastroenterol. 2024 Dec 1;15(12):e00782. doi: 10.14309/ctg.0000000000000782.
United States Multi-Society Task Force colonoscopy surveillance intervals are based solely on adenoma characteristics, without accounting for other risk factors. We investigated whether a risk model including demographic, environmental, and genetic risk factors could individualize surveillance intervals under an "equal management of equal risks" framework.
Using 14,069 individuals from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial who had a diagnostic colonoscopy following an abnormal flexible sigmoidoscopy, we modeled the risk of colorectal cancer, considering the diagnostic colonoscopy finding, baseline risk factors (e.g., age and sex), 19 lifestyle and environmental risk factors, and a polygenic risk score for colorectal cancer. Ten-year absolute cancer risks for each diagnostic colonoscopy finding (advanced adenomas [N = 2,446], ≥3 non-advanced adenomas [N = 483], 1-2 non-advanced adenomas [N = 4,400], and no adenoma [N = 7,183]) were used as implicit risk thresholds for recommended surveillance intervals.
The area under the curve for the model including colonoscopy findings, baseline characteristics, and polygenic risk score was 0.658. Applying the equal management of equal risks framework, 28.2% of individuals with no adenoma and 42.7% of those with 1-2 non-advanced adenomas would be considered high risk and assigned a significantly shorter surveillance interval than currently recommended. Among individuals who developed cancer within 10 years, 52.4% with no adenoma and 48.3% with 1-2 non-advanced adenomas would have been considered high risk and assigned a shorter surveillance interval.
Using a personalized risk-based model has the potential to identify individuals with no adenoma or 1-2 non-advanced adenomas, who are higher risk and may benefit from shorter surveillance intervals.
美国多学会工作组制定的结肠镜检查监测间隔仅基于腺瘤特征,未考虑其他风险因素。我们调查了一个包含人口统计学、环境和遗传风险因素的风险模型是否能在“同等风险同等管理”框架下实现监测间隔的个体化。
我们使用了前列腺、肺、结直肠和卵巢癌筛查试验中的14,069名个体,这些个体在乙状结肠镜检查异常后进行了诊断性结肠镜检查。我们对结直肠癌风险进行建模,考虑诊断性结肠镜检查结果、基线风险因素(如年龄和性别)、19种生活方式和环境风险因素以及结直肠癌的多基因风险评分。将每种诊断性结肠镜检查结果(高级腺瘤[N = 2,446]、≥3个非高级腺瘤[N = 483]、1 - 2个非高级腺瘤[N = 4,400]和无腺瘤[N = 7,183])的十年绝对癌症风险用作推荐监测间隔的隐含风险阈值。
包含结肠镜检查结果、基线特征和多基因风险评分的模型的曲线下面积为0.658。应用同等风险同等管理框架,无腺瘤个体中有28.2%以及有1 - 2个非高级腺瘤的个体中有42.7%将被视为高风险,并被分配比当前推荐显著更短的监测间隔。在10年内患癌的个体中,无腺瘤个体中有52.4%以及有1 - 2个非高级腺瘤的个体中有48.3%会被视为高风险并被分配更短的监测间隔。
使用基于个性化风险的模型有可能识别出无腺瘤或有1 - 2个非高级腺瘤但风险较高且可能从更短监测间隔中获益的个体。